Arkolith/Insider Trading/CLDX/Form 4

Jimenez Freddy A.

SVP & GENERAL COUNSELCelldex Therapeutics, Inc. (CLDX) · full profile →Form 4 · filed Jun 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$269K
Net Open-Market Flow
-$269K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 3, 2024Option exercise(M)8K$10.38$83K34K
Jun 3, 2024Sell(S)8K$33.60$269K26K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 3, 2024Option exercise(M)8K—$028K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-015542) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML